Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017	$ 1,007	$ 17,492,083	$ (18,102,618)	$ (609,528)
Balance (in shares) at Dec. 31, 2017	3,051,538
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	49,336	0	49,336
Capitalized offering costs	0	(46,000)	0	(46,000)
Issuance of common stock, net of issuance costs	$ 102	1,076,792	0	1,076,894
Issuance of common stock, net of issuance costs (in shares)	307,547
Issuance of common stock for warrant exercise	$ 3	99,960	0	99,963
Issuance of common stock for warrant exercise (in shares)	7,673
Issuance of common stock for stock option exercise	$ 2	25,405	0	25,407
Issuance of common stock for stock option exercise (in shares)	3,702
Issuance of warrants	$ 0	342,105	0	342,105
Net loss	0	0	(2,016,932)	(2,016,932)
Balance at Sep. 30, 2018	$ 1,114	19,039,681	(20,119,550)	(1,078,755)
Balance (in shares) at Sep. 30, 2018	3,370,460
Balance at Jun. 30, 2018	$ 1,103	18,599,631	(19,408,342)	(807,608)
Balance (in shares) at Jun. 30, 2018	3,341,143
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	41,691	0	41,691
Capitalized offering costs	0	(2,000)	0	(2,000)
Issuance of common stock, net of issuance costs	$ 6	274,994	0	275,000
Issuance of common stock, net of issuance costs (in shares)	17,942
Issuance of common stock for warrant exercise	$ 3	99,960	0	99,963
Issuance of common stock for warrant exercise (in shares)	7,673
Issuance of common stock for stock option exercise	$ 2	25,405	0	25,407
Issuance of common stock for stock option exercise (in shares)	3,702
Net loss	$ 0	0	(711,208)	(711,208)
Balance at Sep. 30, 2018	$ 1,114	19,039,681	(20,119,550)	(1,078,755)
Balance (in shares) at Sep. 30, 2018	3,370,460
Balance at Dec. 31, 2018	$ 1,128	19,311,529	(21,013,174)	(1,700,517)
Balance (in shares) at Dec. 31, 2018	3,417,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,893,658	0	2,893,658
Issuance of common stock, net of issuance costs	$ 16	749,984	0	750,000
Issuance of common stock, net of issuance costs (in shares)	48,930
Issuance of common stock for antidilution	$ 32	(32)	0	0
Issuance of common stock for antidilution (in shares)	97,960
Issuance of common stock for convertible debt	$ 3	32,950	0	32,953
Issuance of common stock for convertible debt (in shares)	9,683
Issuance of common stock from 401K match	$ 2	29,702	0	29,704
Issuance of common stock from 401K match (in shares)	5,258
Issuance of common stock from equity transaction	$ 33	603,891	0	603,924
Issuance of common stock from equity transaction (in shares)	100,654
Equity from merger transaction	$ 528	15,793,110	0	15,793,638
Equity from merger transaction (in shares)	1,599,178
Net loss	$ 0	0	(2,820,763)	(2,820,763)
Balance at Sep. 30, 2019	$ 1,742	39,414,792	(23,833,937)	15,582,597
Balance (in shares) at Sep. 30, 2019	5,278,850
Balance at Jun. 30, 2019	$ 1,709	38,686,233	(18,082,327)	20,605,615
Balance (in shares) at Jun. 30, 2019	5,177,487
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	120,207	0	120,207
Issuance of common stock from 401K match	$ 0	4,461	0	4,461
Issuance of common stock from 401K match (in shares)	709
Issuance of common stock from equity transaction	$ 33	603,891	0	603,924
Issuance of common stock from equity transaction (in shares)	100,654
Net loss	$ 0	0	(5,751,610)	(5,751,610)
Balance at Sep. 30, 2019	$ 1,742	$ 39,414,792	$ (23,833,937)	$ 15,582,597
Balance (in shares) at Sep. 30, 2019	5,278,850